rdf:type |
|
lifeskim:mentions |
umls-concept:C0021641,
umls-concept:C0030705,
umls-concept:C0071097,
umls-concept:C0072973,
umls-concept:C0087111,
umls-concept:C0277785,
umls-concept:C0332161,
umls-concept:C0332307,
umls-concept:C0441712,
umls-concept:C1801960,
umls-concept:C1883712
|
pubmed:issue |
1
|
pubmed:dateCreated |
2007-12-31
|
pubmed:abstractText |
We examined the relationship between glycemic control, vascular reactivity, and inflammation in type 2 diabetic subjects.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
1935-5548
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
31
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-7
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:17909084-Antihypertensive Agents,
pubmed-meshheading:17909084-Blood Flow Velocity,
pubmed-meshheading:17909084-Blood Glucose,
pubmed-meshheading:17909084-Diabetes Mellitus, Type 2,
pubmed-meshheading:17909084-Diabetic Angiopathies,
pubmed-meshheading:17909084-Drug Therapy, Combination,
pubmed-meshheading:17909084-Forearm,
pubmed-meshheading:17909084-Glucose Clamp Technique,
pubmed-meshheading:17909084-Hemoglobin A, Glycosylated,
pubmed-meshheading:17909084-Hispanic Americans,
pubmed-meshheading:17909084-Humans,
pubmed-meshheading:17909084-Hypoglycemic Agents,
pubmed-meshheading:17909084-Inflammation,
pubmed-meshheading:17909084-Insulin,
pubmed-meshheading:17909084-Insulin Infusion Systems,
pubmed-meshheading:17909084-Placebos,
pubmed-meshheading:17909084-Ramipril,
pubmed-meshheading:17909084-Thiazolidinediones
|
pubmed:year |
2008
|
pubmed:articleTitle |
Addition of pioglitazone and ramipril to intensive insulin therapy in type 2 diabetic patients improves vascular dysfunction by different mechanisms.
|
pubmed:affiliation |
Texas Diabetes Institute, San Antonio, Texas, USA.
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|